Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial

Files

1-s2.0-S2589537020302613-main Safety and immunogenicity evaluation of recombinant BCG vaccine.pdf(903.59 KB)

Date

2020

Authors

Abarca Villaseca, Katia

Rey Jurado, Emma

Muñoz Durango, Natalia

Soto Ramírez, Jorge Andrés

Gálvez Arriagada, Nicolás Marcelo Salvador

Borzutzky Schachter, Arturo

Villarroel del Pino, Luis A.

González Muñoz, Pablo Alberto

González Aramundiz, José Vicente

URI

https://doi.org/10.1016/j.eclinm.2020.100517
https://repositorio.uc.cl/handle/11534/61996

Collections

Artículos de revistas